Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Melanocortin Receptor Agonist Comparison

Melanotan 1 (MT1) differs significantly from related compounds in potency, duration, and side effect profiles, requiring distinct dosing approaches for research applications. Comparative analysis with similar melanocortin receptor agonists demonstrates unique

This comparison does not assign a generated winner or score.

  • Melanotan 1 (MT1) differs significantly from related compounds in potency, duration, and side effect profiles, requiring distinct dosing approaches for research applications. Comparative analysis with similar melanocortin receptor agonists demonstrates unique pharmacological characteristics.
  • Melanotan 1
  • 0.16-0.25 mg/kg
  • Daily
  • 33-41 min
  • MC1R selective
  • Melanotan 2
  • 0.5-2.0 mg
  • 2.5-3 hours
  • MC1R/MC4R activity
  • PT-141
  • 1.75 mg
  • As needed
  • 2.7 hours
  • MC4R selective
  • α-MSH
  • 1-10 mg
  • Multiple daily
  • IV/SC
  • 7-20 min
  • Endogenous hormone
More references

Related material